INSULET CORP
PODDNASDAQ🏆 #783 by market capEarnings Nov 5US Equity
$144.70▲ $1.88 (+1.30%)
🌅 Pre-market$144.70▲ 0.00%Regular close · extended-hours price shown1h—
24h▲ 1.3%
7d▲ 8.6%
14d▼ 15.2%
30d▼ 10.7%
1y▼ 53.2%
🏦Market Cap
$10.02B
Mid Cap
📈Revenue Growth (YoY)
+29.4%
High Growth
📊Gross Margin
71.1%
High
💵FCF Margin
8.7%
Moderate
⚖️P/S Ratio
3.2x
Fair
Otter Score
57
Weak
📊
Analyst Ratings
Price
$144.70
Total
50
Raised
8
Lowered
12
Avg PT
$185.18
H / L
$235 / $144
| Institution | Action | Rating | Date |
|---|---|---|---|
Truist Securities | Downgraded | Buy → Hold | 2026-08-06 |
Benchmark | Reiterated | Buy | 2026-08-06 |
Stifel | Reiterated | Buy | 2026-08-06 |
Wells Fargo | Downgraded | Overweight → Equal Weight | 2026-08-06 |
JP Morgan | Downgraded | Overweight → Neutral | 2026-08-06 |
BTIG | Downgraded | Buy → Neutral | 2026-08-06 |
RBC Capital | Reiterated | Outperform | 2026-07-13 |
Citigroup | Reiterated | Neutral | 2026-07-08 |
Evercore ISI Group | Reiterated | Outperform | 2026-07-06 |
B of A Securities | Reiterated | Buy | 2026-05-18 |
Barclays | Reiterated | Underweight | 2026-05-08 |
Bernstein | Reiterated | Outperform | 2026-05-07 |
Canaccord Genuity | Reiterated | Buy | 2026-05-07 |
Oppenheimer | Reiterated | Outperform | 2026-05-07 |
Rothschild & Co | Downgraded | Buy → Neutral | 2026-04-24 |
Goldman Sachs | Reiterated | Buy | 2026-04-09 |
Leerink Partners | Reiterated | Outperform | 2026-02-19 |
UBS | Upgraded | Neutral → Buy | 2025-11-19 |
Jefferies | Reiterated | Buy | 2025-11-06 |
Raymond James | Reiterated | Outperform | 2025-05-27 |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2025-05-13 |
Piper Sandler | Reiterated | Overweight | 2025-02-21 |
TD Cowen | Reiterated | Buy | 2025-01-03 |
Morgan Stanley | Reiterated | Overweight | 2024-11-11 |
OTR Global | Downgraded | Positive → Mixed | 2024-06-10 |
Baird | Upgraded | Neutral → Outperform | 2023-12-21 |
SVB Leerink | Reiterated | Outperform | 2022-05-06 |
CFRA | Reiterated | Sell | 2020-05-08 |
Piper Jaffray | Reiterated | Overweight | 2019-11-18 |
Guggenheim Securities | Downgraded | Buy → Neutral | 2019-10-03 |
Guggenheim | Downgraded | Buy → Neutral | 2019-10-03 |
BMO Capital | Reiterated | Outperform | 2019-08-06 |
Northland Capital Markets | Downgraded | Outperform → Market Perform | 2019-06-10 |
Northland | Downgraded | Outperform → Market Perform | 2019-06-10 |
BTIG Research | Upgraded | Neutral → Buy | 2019-05-06 |
Berenberg | Reiterated | Buy | 2018-04-20 |
Cowen & Co. | Reiterated | Outperform | 2018-02-22 |
Stephens & Co. | Reiterated | Equal Weight | 2018-02-22 |
B. Riley FBR | Reiterated | Neutral | 2016-09-27 |
William Blair | Upgraded | Market Perform → Outperform | 2016-04-29 |
Empire Asset Management | Reiterated | Sell | 2016-02-25 |
PiperJaffray | Reiterated | Overweight | 2015-08-13 |
Northland Securities | Upgraded | Market Perform → Outperform | 2015-05-04 |
Leerink Swann | Reiterated | Outperform | 2015-01-21 |
JMP Securities | Reiterated | Market Outperform | 2014-11-06 |
Wedbush | Reiterated | Outperform | 2014-10-28 |
Barrington Research | Upgraded | Market Perform → Outperform | 2014-05-16 |
Feltl & Co. | Upgraded | Sell → Hold | 2014-05-08 |
Wunderlich | Downgraded | Buy → Hold | 2013-06-07 |
Wunderlich Securities | Downgraded | Buy → Hold | 2013-06-07 |
One row per institution, most recent rating